Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,422.00    32.00 (1.34%)
Bid:
2,420.00
Ask:
2,424.00
Spread: 4.00 (0.165%)
Market Cap: £7.78b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

28 Jun 2017 07:00

RNS Number : 3282J
Bunzl PLC
28 June 2017
 

28 June 2017

 

BUNZL PRE CLOSE STATEMENT AND

ACQUISITIONS IN SPAIN AND CANADA

 

Bunzl plc, the international distribution and outsourcing Group, is updating the market today relating to the six months ending 30 June 2017 prior to entering its closed period.

 

Overall trading is consistent with expectations at the time of the first quarter trading statement in April. Group revenue for the half year is expected to have increased by 7% at constant exchange rates due to the improved underlying growth of between 3% and 4% and a similar impact from acquisitions. In addition, currency translation movements are expected to have increased the constant exchange revenue growth by 12%. As previously indicated, the underlying revenue growth is mainly due to the additional business won, albeit at lower margins, in North America towards the end of 2016.

 

Acquisitions continue to be an important part of the Company's strategy for growth and Bunzl also today announces that it has purchased three further businesses in Spain and Canada.

 

Tecnopacking, which is based near Valencia, is engaged in the distribution of industrial and disposable packaging products to end users operating in a variety of different sectors throughout Spain as well as in Portugal. Revenue in 2016 was €38 million.

 

Bunzl has also acquired two separate businesses in Canada. AMFAS and Western Safety, which are both based in Vancouver, are distributors of commercial and industrial first aid and safety supplies, including a full range of personal protection equipment, to end user customers throughout Western Canada. The businesses, which together have aggregated annualised revenue of C$16 million, also provide safety-related services including training programmes and other workplace safety solutions.

 

Bunzl has now acquired eight businesses so far this year for a total committed spend of approximately £290 million, adding aggregate annualised revenue of £370 million. With an active acquisition pipeline and ongoing discussions taking place, the Company expects to complete further acquisitions during the remainder of the year.

 

Commenting on the acquisitions, Frank van Zanten, Chief Executive of Bunzl said:

 

"The acquisition of Tecnopacking has further extended our operations in Spain which have grown significantly in recent years with total annualised revenue now approaching €200 million. We have also seen rapid growth in Canada with the purchase of AMFAS and Western Safety bringing the total number of businesses acquired there since the beginning of 2015 to nine. We are delighted to welcome all of their employees to the Group.

 

I am particularly pleased to see that the level of acquisition activity has picked up this year with the purchase of a number of high quality businesses which have allowed us to expand the Group further. With a promising pipeline of additional opportunities, I would expect us to complete further acquisitions as the year progresses."

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive

Brian May, Finance Director

Tel: +44 (0)20 7725 5000

Tulchan

David Allchurch

Martin Robinson

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBXGDLGUDBGRR
Date   Source Headline
1st Apr 202211:13 amRNSTotal Voting Rights
17th Mar 20224:15 pmRNSAnnual Financial Report
15th Mar 202211:30 amRNSDirector Declaration
3rd Mar 20225:07 pmRNSDirector/PDMR Shareholding
2nd Mar 20226:12 pmRNSDirector/PDMR Shareholding
2nd Mar 20225:36 pmRNSDirector/PDMR Shareholding
1st Mar 20225:58 pmRNSDirector/PDMR Shareholding
1st Mar 20223:00 pmRNSTotal Voting Rights
1st Mar 20229:00 amRNSDirector Declaration
28th Feb 20227:00 amRNSAnnual Financial Report
3rd Feb 20224:06 pmRNSDirector/PDMR Shareholding
2nd Feb 20225:30 pmRNSDirectorate Change
1st Feb 202210:58 amRNSTotal Voting Rights
12th Jan 202212:15 pmRNSDirector/PDMR Shareholding
12th Jan 20227:00 amRNSAcquisition
10th Jan 20225:34 pmRNSDirector/PDMR Shareholding
7th Jan 202211:54 amRNSDirector/PDMR Shareholding
4th Jan 20225:56 pmRNSTotal Voting Rights
15th Dec 20217:00 amRNSTrading Statement
10th Dec 20213:18 pmRNSDirector/PDMR Shareholding
8th Dec 20214:30 pmRNSDirector Declaration
8th Dec 20218:00 amRNSAdditional Listing
3rd Dec 20214:27 pmRNSDirector/PDMR Shareholding
1st Dec 20214:50 pmRNSDirector/PDMR Shareholding
1st Dec 202110:20 amRNSTotal Voting Rights
18th Nov 20217:00 amRNSAcquisition
10th Nov 20213:00 pmRNSPublication of Admission Particulars
4th Nov 20215:41 pmRNSDirector/PDMR Shareholding
3rd Nov 202112:35 pmRNSDirector/PDMR Shareholding
3rd Nov 202112:35 pmRNSDirector/PDMR Shareholding
1st Nov 20213:14 pmRNSTotal Voting Rights
1st Nov 20219:00 amRNSBlock listing Interim Review
29th Oct 20211:10 pmRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSTrading Statement
19th Oct 20215:12 pmRNSDirector/PDMR Shareholding
19th Oct 20215:11 pmRNSDirector/PDMR Shareholding
11th Oct 20217:00 amRNSCapital Markets Day
8th Oct 20212:28 pmRNSDirector/PDMR Shareholding
8th Oct 20212:24 pmRNSDirector/PDMR Shareholding
5th Oct 202110:16 amRNSDirector/PDMR Shareholding
1st Oct 202112:36 pmRNSTotal Voting Rights
14th Sep 20217:00 amRNSAcquisition
3rd Sep 202112:30 pmRNSDirector/PDMR Shareholding
1st Sep 20214:00 pmRNSTotal Voting Rights
31st Aug 20214:30 pmRNSDividend Declaration
31st Aug 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSAcquisition
4th Aug 202111:24 amRNSDirector/PDMR Shareholding
2nd Aug 20213:40 pmRNSTotal Voting Rights
14th Jul 20214:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.